WO2001079473A3 - Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations - Google Patents

Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations Download PDF

Info

Publication number
WO2001079473A3
WO2001079473A3 PCT/US2001/040483 US0140483W WO0179473A3 WO 2001079473 A3 WO2001079473 A3 WO 2001079473A3 US 0140483 W US0140483 W US 0140483W WO 0179473 A3 WO0179473 A3 WO 0179473A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid molecules
prolyl oligopeptidase
family member
expression vectors
Prior art date
Application number
PCT/US2001/040483
Other languages
English (en)
Other versions
WO2001079473A2 (fr
Inventor
Rachel A Meyers
Mark Williamson
Original Assignee
Rachel A Meyers
Mark Williamson
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rachel A Meyers, Mark Williamson, Millennium Pharm Inc filed Critical Rachel A Meyers
Priority to EP01931127A priority Critical patent/EP1280922A2/fr
Priority to AU2001257594A priority patent/AU2001257594A1/en
Publication of WO2001079473A2 publication Critical patent/WO2001079473A2/fr
Publication of WO2001079473A3 publication Critical patent/WO2001079473A3/fr
Priority to US10/170,789 priority patent/US7070947B2/en
Priority to US11/151,601 priority patent/US7198930B2/en
Priority to US11/636,948 priority patent/US7282360B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des molécules isolées d'acide nucléique, appelées molécules d'acide nucléique 21953, qui codent pour de nouveaux membres de la famille de la prolyl oligopeptidase. L'invention concerne également des molécules d'acide nucléique antisens, des vecteurs d'expression de recombinaison contenant ces molécules d'acide nucléique 21953, des cellules hôtes dans lesquelles des vecteurs d'expression ont été introduits et des animaux transgéniques dans lesquels un gène 21953 a été introduit ou disloqué. L'invention concerne en outre des protéines isolées, des protéines de fusion, des peptides antigéniques 21953 ainsi que des anticorps anti-21953. L'invention concerne enfin des méthodes diagnostiques faisant appel aux compositions selon l'invention.
PCT/US2001/040483 2000-02-29 2001-04-11 Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations WO2001079473A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP01931127A EP1280922A2 (fr) 2000-04-18 2001-04-11 Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations
AU2001257594A AU2001257594A1 (en) 2000-04-18 2001-04-11 21953, a novel human prolyl oligopeptidase family member and uses thereof
US10/170,789 US7070947B2 (en) 2000-02-29 2002-06-13 Human protein kinase, phosphatase, and protease family members and uses thereof
US11/151,601 US7198930B2 (en) 2000-02-29 2005-06-13 Human protein kinase, phosphatase, and protease family members and uses thereof
US11/636,948 US7282360B2 (en) 2000-02-29 2006-12-11 Human protein kinase, phosphatase, and protease family members and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19750800P 2000-04-18 2000-04-18
US60/197,508 2000-04-18

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/170,789 Continuation-In-Part US7070947B2 (en) 2000-02-29 2002-06-13 Human protein kinase, phosphatase, and protease family members and uses thereof

Publications (2)

Publication Number Publication Date
WO2001079473A2 WO2001079473A2 (fr) 2001-10-25
WO2001079473A3 true WO2001079473A3 (fr) 2002-04-25

Family

ID=22729698

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/040483 WO2001079473A2 (fr) 2000-02-29 2001-04-11 Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations

Country Status (3)

Country Link
EP (1) EP1280922A2 (fr)
AU (1) AU2001257594A1 (fr)
WO (1) WO2001079473A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0101760D0 (en) * 2001-01-23 2001-03-07 Glaxo Group Ltd Novel protein
EP1422293A1 (fr) * 2002-11-25 2004-05-26 F. Hoffmann-La Roche Ag Structure cristalline de dipeptidylpeptidase IV
WO2005106021A1 (fr) * 2004-04-28 2005-11-10 Bayer Healthcare Ag Diagnostics et therapeutique de maladies associees a la dipeptidyle peptidase 8 (dpp8)
RU2542414C2 (ru) * 2010-07-15 2015-02-20 Олег Ильич Эпштейн Лекарственное средство для лечения эректильных дисфункций и способ лечения эректильных дисфункций

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001010903A2 (fr) * 1999-08-09 2001-02-15 Incyte Genomics, Inc. Proteases et inhibiteurs de proteases
WO2001019866A1 (fr) * 1999-09-10 2001-03-22 The University Of Sydney Dipeptidyl peptidases
WO2001083775A2 (fr) * 2000-05-04 2001-11-08 Incyte Genomics, Inc. Proteases
WO2001098468A2 (fr) * 2000-06-16 2001-12-27 Incyte Genomics, Inc. Proteases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001010903A2 (fr) * 1999-08-09 2001-02-15 Incyte Genomics, Inc. Proteases et inhibiteurs de proteases
WO2001019866A1 (fr) * 1999-09-10 2001-03-22 The University Of Sydney Dipeptidyl peptidases
WO2001083775A2 (fr) * 2000-05-04 2001-11-08 Incyte Genomics, Inc. Proteases
WO2001098468A2 (fr) * 2000-06-16 2001-12-27 Incyte Genomics, Inc. Proteases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL/GENBANK NEDO human cDNA sequencing project; 15 January 2000 (2000-01-15), KAWAKAMI ET AL: "Homo sapiens cDNA FLJ20283 fis, clone HEP04088", XP002188742 *
DATABASE GENEBANK Homo sapiens clone for prolyl endopeptidase; 20 November 1999 (1999-11-20), YOSHIMOTO ET AL.: "Cloning and expression of the cDNA encoding prolyl oligopeptidase (prolyl endopeptidase) from human brain", XP002188743 *

Also Published As

Publication number Publication date
AU2001257594A1 (en) 2001-10-30
EP1280922A2 (fr) 2003-02-05
WO2001079473A2 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
WO2001090323A3 (fr) Nouveau membre de la famille des lipoxydases humaines appele 46638, et ses utilisations
WO2001090325A3 (fr) 50365, un nouveau membre de la famille hexokinase et utilisations
WO2001096392A3 (fr) Molecules 22109, constituant un nouveau membre de la famille des thioredoxines humaines et utilisations correspondantes
WO2002002760A3 (fr) 25869, nouvelle carboxylesterase humaine et ses utilisations
WO2002026803A3 (fr) 22108 et 47916, nouveaux membres de la famille des thioredoxines humaines et leurs applications
WO2001079473A3 (fr) Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations
WO2001083719A3 (fr) 25692, nouveau membre de la famille humaine o-methyltransferase et utilisation associee
WO2001094563A3 (fr) 46980, nouveau membre de la famille de la neuroligine humaine et utilisations associees
WO2001064904A3 (fr) Membres de la famille transferase 25324, 50287, 28899, 47007, et 42967 et utilisations de ces derniers
WO2002020801A3 (fr) 26199, 33530, 33949, 47148, 50226, et 58764, nouveaux membres de la famille des transferases humaines et utilisations de ceux-ci
WO2001090145A3 (fr) 57805, nouvel element de la famille des cadherines humaines et utilisations correspondantes
WO2002029040A3 (fr) 25219, nouvelle aminotransferase humaine et ses utilisations
WO2002008400A3 (fr) 25233, nouvelle aminotransferase humaine et ses utilisations
WO2002002761A3 (fr) 57658, nouvelle uridine kinase humaine et utilisations correspondantes
WO2002050256A8 (fr) 53010, nouveau membre de la famille des carboxylesterases humaines et utilisations
WO2002029037A3 (fr) 57800, nouvelle cadherine humaine et ses applications
WO2001073051A3 (fr) 46743 et 27417, nouveaux membres de la famille acyltransferase humaine
WO2002038773A3 (fr) 32544, nouvelle phospholipase c humaine et ses applications
WO2001079498A3 (fr) 16051a and 16051b codant pour des membres de la famille pdz humains et leurs utilisations
WO2002051992A3 (fr) 21163, nouvelle propyle oligopeptidase humaine et utilisations correspondantes
WO2001083720A3 (fr) Molecule 23686, une nouvelle aminotransferase et ses applications
WO2002051991A3 (fr) 17903, nouvelle aminopeptidase humaine et utilisations correspondantes
WO2001075119A3 (fr) 21509 et 33770, membres de la famille des deshydrogenases humaines et utilisations associees
WO2002016603A3 (fr) 23228, nouveau membre de la famille des tetraspanines humaines, et utilisations correspondantes
WO2002008397A3 (fr) 7716, une nouvelle atpase humaine et les utilisations de celle-ci

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001931127

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001931127

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001931127

Country of ref document: EP